Enter your email address to receive updates
Search By Trade Name
Trade name | Generic name | Classification
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z 
Generic Name
Telmisartan
Trade Name
Micardis
Risk Category
D*
  • Positive evidence of human fetal risk exists.
  • Potential benefits may warrant use of the drug in pregnant women despite potential risks (e.g. life threatening situations or serious illness).
The risk category is C in first trimester.
FDA Pregnancy Risk Categories

Place (not click) your mouse cursor over the bold words in the text below to receive description

Indication
Indication
  • Angiotensin-II receptor antagonist.
  • Antihypertensive.
  • Fetal Risk
    Fetal Risk
  • toxic in animals.
  • Contraindicated in pregnancy.
  • In general all the drugs that act directly on the renin-angiotensin system should be avoided in the second and third trimesters as they can effect fetal and neonatal blood pressure control and renal function resulting in kidney injury and oligohydramnios.
  • Also possible skull defects and fetal death.
  • Breast Feeding
    Breast Feeding
  • Contraindicated in lactation as well.
  • See Losartan, Valsartan.
  • Unknown excretion into milk, but should be avoided.
  • Other Trade Names
     
    The information on this Web site is not intended as a substitute for the advice and care of your doctor or other health-care provider. Always consult your doctor if you have any questions about exposures during pregnancy and lactation, and before you take any medications. Please read the Terms and Conditions before using this website.
      Tell A Friend

        You
    Name
    Email
        Your Friend
    Name
    Email
        Comments
     7   +   4    =  
      Calculate Birth Date
    Enter the first day of the last menstruation
    Month Day Year
    Result
    Month Day Year